title: Regional Fos expression induced by morphine withdrawal in the 7-day-old rat.
abstract: Human infants are often exposed to opiates chronically but the mechanisms by which opiates induce dependence in the infant are not well studied. In the adult the brain regions involved in the physical signs of opiate withdrawal include the periaqueductal gray area, the locus coeruleus, amygdala, ventral tegmental area, nucleus accumbens, hypothalamus, and spinal cord. Microinjection studies show that many of these brain regions are involved in opiate withdrawal in the infant rat. Our goal here was to determine if these regions become metabolically active during physical withdrawal from morphine in the infant rat as they do in the adult. Following chronic morphine or saline treatment, withdrawal was precipitated in 7-day-old pups with the opiate antagonist naltrexone. Cells positive for Fos-like immunoreactivity were quantified within select brain regions. Increased Fos-like labeled cells were found in the periaqueductal gray, nucleus accumbens, locus coeruleus, and spinal cord. These are consistent with other studies showing that the neural circuits underlying the physical signs of opiate withdrawal are similar in the infant and adult.
authors.affiliation: Department of Psychology, Hunter College and the Graduate Center, City University of New York, New York, NY 10016, USA.
authors.forename: Anika A
authors.initials: AA
authors.lastname: McPhie
authors.forename: Gordon A
authors.initials: GA
authors.lastname: Barr
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D002452:Cell Count; D005260:Female; D007150:Immunohistochemistry; D008125:Locus Coeruleus / Q000378:metabolism; D008297:Male; D009020:Morphine / Q000008:administration & dosage; D009021:Morphine Dependence / Q000378:metabolism*; D009271:Naltrexone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009294:Narcotics / Q000008:administration & dosage; D009714:Nucleus Accumbens / Q000378:metabolism; D010487:Periaqueductal Gray / Q000378:metabolism; D011247:Pregnancy; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*; D051381:Rats; D020318:Rats, Long-Evans; D013116:Spinal Cord / Q000378:metabolism; D013375:Substance Withdrawal Syndrome / Q000378:metabolism*
chemical_list: D009292:Narcotic Antagonists; D009294:Narcotics; D016760:Proto-Oncogene Proteins c-fos; D009271:Naltrexone; D009020:Morphine
references.citation: Brain Res. 1985 Apr 15;332(1):69-78
references.pmid: 4039615
references.citation: Trends Pharmacol Sci. 2001 Aug;22(8):404-8
references.pmid: 11479002
references.citation: Brain Res Dev Brain Res. 2000 Nov 30;124(1-2):73-80
references.pmid: 11113514
references.citation: Pharmacology. 1996 Feb;52(2):86-91
references.pmid: 8851629
references.citation: Pain. 1995 Mar;60(3):257-65
references.pmid: 7596621
references.citation: Brain Res Dev Brain Res. 1992 Mar 20;66(1):133-6
references.pmid: 1600627
references.citation: Neuroscience. 1996 May;72(1):233-42
references.pmid: 8730720
references.citation: Science. 1987 Jul 10;237(4811):192-7
references.pmid: 3037702
references.citation: Neurosci Lett. 1990 Feb 16;109(3):309-14
references.pmid: 2109845
references.citation: Eur J Pharmacol. 1992 Apr 29;215(1):35-42
references.pmid: 1516648
references.citation: Pharmacol Biochem Behav. 1997 Aug;57(4):779-83
references.pmid: 9259006
references.citation: Crit Care Med. 1994 Feb;22(2):334-42
references.pmid: 8306694
references.citation: Dev Psychobiol. 2001 Jul;39(1):1-7
references.pmid: 11507704
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):466-72
references.pmid: 1620246
references.citation: Neuroscience. 2001;105(1):7-17
references.pmid: 11483296
references.citation: Brain Res. 1986 Dec 3;399(1):181-4
references.pmid: 3801919
references.citation: Psychopharmacology (Berl). 2000 Jun;150(3):325-36
references.pmid: 10923761
references.citation: J Neurosci. 2002 May 1;22(9):3663-72
references.pmid: 11978842
references.citation: Synapse. 1995 Sep;21(1):54-9
references.pmid: 8525462
references.citation: J Pharmacol Exp Ther. 2000 Aug;294(2):531-8
references.pmid: 10900229
references.citation: Jpn J Pharmacol. 2002 Nov;90(3):270-5
references.pmid: 12499582
references.citation: J Neurosci. 1998 Dec 15;18(24):10269-76
references.pmid: 9852564
references.citation: Neuropsychopharmacology. 2002 Mar;26(3):301-10
references.pmid: 11850145
references.citation: J Neurosci. 2005 Feb 9;25(6):1366-74
references.pmid: 15703390
references.citation: Neurosci Lett. 1995 Jan 2;183(1-2):79-82
references.pmid: 7746492
references.citation: Proc Natl Acad Sci U S A. 1918 Sep;4(9):280-3
references.pmid: 16586794
references.citation: Synapse. 2001 Sep 15;41(4):345-50
references.pmid: 11494405
references.citation: Fed Proc. 1985 Apr;44(7):2314-7
references.pmid: 3884386
references.citation: Pharmacol Biochem Behav. 1988 Jan;29(1):175-81
references.pmid: 3353423
references.citation: Brain Res. 1995 May 15;679(2):189-99
references.pmid: 7633880
references.citation: Science. 1988 Nov 4;242(4879):715-23
references.pmid: 2903550
references.citation: Cochrane Database Syst Rev. 2002;(3):CD002059
references.pmid: 12137642
references.citation: Pain. 1997 Dec;73(3):347-354
references.pmid: 9469524
references.citation: Psychol Rep. 1966 Feb;18(1):221-2
references.pmid: 5908481
references.citation: Neuroscience. 1990;37(3):767-73
references.pmid: 2247222
references.citation: J Pharmacol Exp Ther. 1989 Feb;248(2):538-45
references.pmid: 2918470
references.citation: Science. 1997 Aug 8;277(5327):812-4
references.pmid: 9242609
references.citation: Behav Brain Res. 2001 Nov 29;126(1-2):147-57
references.pmid: 11704260
references.citation: Synapse. 2001 Feb;39(2):139-51
references.pmid: 11180501
references.citation: Pain. 2003 Aug;104(3):437-447
references.pmid: 12927616
references.citation: Endocr Rev. 1993 Feb;14(1):94-106
references.pmid: 8491157
references.citation: Psychopharmacologia. 1976 Mar 16;46(2):141-7
references.pmid: 986052
references.citation: Early Hum Dev. 1991 Jul;26(1):61-7
references.pmid: 1914989
references.citation: Brain Res. 1990 Aug 20;525(2):256-66
references.pmid: 1701330
references.citation: J Histochem Cytochem. 1981 Apr;29(4):577-80
references.pmid: 6166661
references.citation: Nature. 1978 Nov 9;276(5684):186-8
references.pmid: 216919
references.citation: Int J Dev Neurosci. 2004 Aug-Oct;22(5-6):379-95
references.pmid: 15380837
references.citation: J Physiol. 1997 Jan 15;498 ( Pt 2):463-72
references.pmid: 9032693
references.citation: Pharmacol Ther. 1987;35(1-2):227-63
references.pmid: 3321101
references.citation: Annu Rev Neurosci. 1984;7:443-78
references.pmid: 6324646
references.citation: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002053
references.pmid: 16034870
references.citation: Life Sci. 1993;52(22):PL245-9
references.pmid: 7684108
references.citation: J Pharmacol Exp Ther. 1992 May;261(2):669-77
references.pmid: 1578378
references.citation: J Pharmacol Exp Ther. 1995 Jun;273(3):1361-74
references.pmid: 7791109
references.citation: Eur J Pharmacol. 1983 Oct 14;94(1-2):35-42
references.pmid: 6686142
references.citation: Eur J Pharmacol. 1999 May 28;373(1):1-11
references.pmid: 10408246
references.citation: Pediatrics. 2008 Sep;122(3):e601-7
references.pmid: 18694901
references.citation: Neurosci Lett. 1998 Nov 20;257(1):9-12
references.pmid: 9857953
references.citation: Eur J Pharmacol. 1997 Dec 11;340(2-3):161-7
references.pmid: 9537810
references.citation: Brain Res. 1990 Jun 4;518(1-2):6-10
references.pmid: 2390728
references.citation: Psychopharmacology (Berl). 1989;98(4):530-4
references.pmid: 2505294
references.citation: Psychopharmacologia. 1964 Dec 7;6(6):410-6
references.pmid: 4378552
references.citation: J Neurosci. 2002 May 15;22(10):4153-62
references.pmid: 12019333
references.citation: Behav Neurosci. 1995 Dec;109(6):1189-98
references.pmid: 8748967
references.citation: Psychopharmacologia. 1973 Oct 23;33(1):19-38
references.pmid: 4797644
references.citation: Brain Res. 1993 Oct 8;624(1-2):19-28
references.pmid: 7902768
references.citation: Am J Crit Care. 1998 Sep;7(5):364-9
references.pmid: 9740886
references.citation: Neuropsychopharmacology. 2000 Sep;23(3):307-15
references.pmid: 10942854
references.citation: Neuropharmacology. 1992 Dec;31(12):1231-41
references.pmid: 1335131
references.citation: Psychopharmacology (Berl). 1993;112(4):521-4
references.pmid: 7532866